Cumberland Pharmaceuticals Inc (CPIX)

Trade CPIX now with
3/18/2020 4:14:34 PM Cumberland Pharma Q4 Loss/share $0.06 Vs. Loss $0.14 Year Ago
12/2/2019 8:15:07 AM Cumberland Receives FDA Approval For RediTrex, Its New Line Of Methotrexate Products
9/24/2019 9:38:48 AM Cumberland Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program
8/14/2019 4:21:26 PM Cumberland Pharma Q2 Loss/share $0.04 Vs Loss $0.05 Year Ago
5/15/2019 9:40:04 AM Cumberland Pharma Signs Licensing Agreement For Distribution In China
3/29/2019 10:51:06 AM Cumberland Pharmaceuticals Begins Strategic Review Of Its Branded Product Portfolio
2/26/2019 4:40:38 PM Cumberland Pharma Q4 Loss/share $0.14 Vs. Loss $0.05 Year Ago
11/13/2018 4:13:10 PM Cumberland Pharma Q3 Loss/share $0.11 Vs. Loss $0.05 Year Ago
11/6/2018 8:47:29 AM Cumberland Pharma To Acquire VIBATIV
8/13/2018 10:01:41 AM Cumberland Pharma Appoints Adam Haeberle As Senior Director
4/17/2018 2:33:06 PM B. Riley FBR Initiates Cumberland Pharmaceuticals Inc (CPIX) At Buy With $9.25 Price Target